Pharmaceutical Executive
August 01, 2013
Column
0
0
With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation.
August 01, 2013
Column
0
0
The ?70 billion budget is still subject to final agreement on the European Union's overall spending plans for 2014-2020.
August 01, 2013
Country Report
0
0
On the Northern fringes of Europe, those who want to believe that there is a sustainable future for the old continent's generous healthcare systems find a beacon of hope.
August 01, 2013
Column
0
0
The best way to grow in the pharma industry is to think small.
August 01, 2013
Features
0
0
Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate.
August 01, 2013
Column
0
0
Rate cuts and fraud concerns create problems for Part D plans and Part B providers.
August 01, 2013
Column
0
0
In the spirit of lawn chair cogitation and hammock-spun reverie, Pharm Exec invites you to submit your own verses-pharma-related, of course-to be published on our website in late August.
August 01, 2013
Features
0
0
Reaching skittish consumers through objective, storydriven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges, writes Peter Houston.
August 01, 2013
From the Editor
0
0
The trade media is ablaze with lurid accounts of bribery, tax fraud, and other illicit promotional activities in China-ironically, the country touted as guarantor of our industry's future.
August 01, 2013
Features
0
0
As growth in the BRICs and other emerging economies begins to stabilize, companies are finally turning their attention to Africa-a hidden trove of potential that is only as good as you make it.